Literature DB >> 2776820

Use of prescription forgeries in a drug abuse surveillance network.

U Bergman1, M L Dahl-Puustinen.   

Abstract

Data on forged prescriptions in Sweden in 1982-1986 were studied as an indicator in an epidemiological survey of medication abuse. The annual number of prescription forgeries doubled during the 5-year period. Psychotropic drugs accounted for 62% and analgesics for 25% of all forgeries. Benzodiazepines were the major single drug group, comprising 52% of all forgeries during the period. The major benzodiazepines on the market in Sweden (diazepam, oxazepam, nitrazepam and flunitrazepam) were the subject of largest number of forgeries. When calculated in relation to the utilization (either total sales or the number of prescriptions), the analgesics codeine, pentazocine and ketobemidone were clearly at the head of the list, suggesting greater abuse liability of these drugs. It is suggested that the data on forged prescriptions can be used as a "signalling mechanism" in epidemiological surveillance of medication abuse, aimed at detecting changes in the prevalence as well as in the pattern of abuse.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776820     DOI: 10.1007/BF00637747

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Drug-related problems in London accident and emergency departments. A twelve month survey.

Authors: 
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

2.  Abuse of buprenorphine.

Authors:  J Strang
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

3.  Measurement of drug utilization in Sweden: methodological and clinical implications.

Authors:  U Bergman; F Sjöqvist
Journal:  Acta Med Scand Suppl       Date:  1984

4.  Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.

Authors:  R R Griffiths; D R McLeod; G E Bigelow; I A Liebson; J D Roache
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Relative abuse of diazepam and oxazepam: prescription forgeries and theft/loss reports in Sweden.

Authors:  U Bergman; R R Griffiths
Journal:  Drug Alcohol Depend       Date:  1986-02       Impact factor: 4.492

6.  Continuous recording of drug prescribing in Sweden 1974-1983. Methods and examples of utilization of data.

Authors:  A Wessling
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  6 in total
  7 in total

1.  Multiple Determinants of Specific Modes of Prescription Opioid Diversion.

Authors:  Theodore J Cicero; Steven P Kurtz; Hilary L Surratt; Gladys E Ibanez; Matthew S Ellis; Maria A Levi-Minzi; James A Inciardi
Journal:  J Drug Issues       Date:  2011

2.  Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator.

Authors:  Vincent Pradel; Catherine Delga; Frank Rouby; Joëlle Micallef; Maryse Lapeyre-Mestre
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

3.  The Diversion of Prescription Opioid Analgesics.

Authors:  James A Inciardi; Hilary L Surratt; Yamilka Lugo; Theodore J Cicero
Journal:  Law Enforc Exec Forum       Date:  2007-11

4.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

5.  Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics.

Authors:  A E Eggen; M Andrew
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment.

Authors:  James A Inciardi; Hilary L Surratt; Theodore J Cicero; Ronald A Beard
Journal:  Pain Med       Date:  2009-04       Impact factor: 3.750

7.  Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey.

Authors:  Olivia Boeuf; Maryse Lapeyre-Mestre
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.